iShares Biotechnology ETF Rating

→ The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad)

$136.69

-0.60 (-0.44%)

(As of 05/17/2024 08:53 PM ET)

iShares Biotechnology ETF Aggregate Rating and Price Target (2024)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

IBB Aggregate Rating

Moderate Buy

2.57

Holdings in IBB have an aggregate rating of Moderate Buy based on 664 analyst ratings issued in the past year covering 50 companies (84.1% of the portfolio).

IBB Aggregate Price Target

$158.13
15.69% Upside

High Prediction	$207.67
Average Prediction	$158.13
Low Prediction	$114.84

Holdings in IBB have an aggregate price target of $158.13 and a range of $114.84 to $207.67 covering 50 companies (84.1% of the portfolio).

IBB Consensus Ratings of Holdings

Strong Buy	0 Strong Buy rating(s)
Buy	6 Buy rating(s)
Moderate Buy	32 Moderate Buy rating(s)
Hold	11 Hold rating(s)
Reduce	1 Reduce rating(s)
Sell	0 Sell rating(s)
Strong Sell	0 Strong Sell rating(s)

Ratings for Stocks Held by iShares Biotechnology ETF

Strong Sell

Sell

Reduce

Hold

Moderate Buy

Buy

Strong Buy

Ratings for the Top 50 IBB Holdings

Export to Excel

Weight In ETF	Company	Share Price	MarketRank™	Consensus Rating Score	Consensus Price Target	Possible Upside	Number of Ratings	Indicator(s)
8.62%	AMGN Amgen	$312.47 -0.7%	5 of 5 stars	2.52	$305.65	-2.2%	21
8.22%	REGN Regeneron Pharmaceuticals	$982.29 +1.5%	4 of 5 stars	2.76	$989.36	0.7%	21	Insider Selling Positive News
8.06%	VRTX Vertex Pharmaceuticals	$445.21 +1.0%	4 of 5 stars	2.48	$432.18	-2.9%	25	Analyst Upgrade
7.68%	GILD Gilead Sciences	$67.72 -0.2%	5 of 5 stars	2.35	$83.69	23.6%	17
4.34%	MRNA Moderna	$132.90 +0.2%	4 of 5 stars	2.24	$126.46	-4.8%	17	Insider Selling
4.11%	IQV IQVIA	$231.18 -1.6%	5 of 5 stars	2.80	$257.57	11.4%	15
3.18%	BIIB Biogen	$230.57 +0.2%	5 of 5 stars	2.65	$288.46	25.1%	26	Positive News
2.73%	MTD Mettler-Toledo International	$1,522.75 -0.5%	4 of 5 stars	2.14	$1,257.14	-17.4%	7
2.04%	ARGX argenx	$365.81 -2.9%	3 of 5 stars	2.71	$524.68	43.4%	21	Earnings Report
2.02%	ILMN Illumina	$111.07 -3.0%	5 of 5 stars	2.30	$164.65	48.2%	20
1.97%	BNTX BioNTech	$90.61 -2.5%	1 of 5 stars	2.20	$111.70	23.3%	10	Positive News
1.94%	ALNY Alnylam Pharmaceuticals	$149.40 -1.2%	5 of 5 stars	2.59	$216.19	44.7%	17	Short Interest ↑
1.92%	WAT Waters	$355.95 -1.3%	3 of 5 stars	1.90	$305.78	-14.1%	10
1.61%	GMAB Genmab A/S	$29.98 +1.1%	3 of 5 stars	2.38	$48.50	61.8%	13	Analyst Forecast
1.60%	BMRN BioMarin Pharmaceutical	$77.56 +0.8%	5 of 5 stars	2.57	$106.11	36.8%	21	Analyst Downgrade High Trading Volume
1.40%	NBIX Neurocrine Biosciences	$142.29 +0.3%	5 of 5 stars	2.79	$148.96	4.7%	24
1.35%	BGNE BeiGene	$172.85 +1.1%	3 of 5 stars	2.80	$251.93	45.8%	10	Positive News
1.21%	INCY Incyte	$57.10 +0.4%	5 of 5 stars	2.47	$74.93	31.2%	17
1.21%	TECH Bio-Techne	$83.81 +1.2%	4 of 5 stars	2.82	$80.50	-3.9%	11	Positive News
1.19%	CRL Charles River Laboratories International	$221.61 -1.4%	5 of 5 stars	2.64	$255.27	15.2%	11	Analyst Upgrade
1.19%	SRPT Sarepta Therapeutics	$131.38 -1.0%	4 of 5 stars	2.86	$163.94	24.8%	14	Analyst Forecast
1.15%	UTHR United Therapeutics	$274.26 +0.7%	5 of 5 stars	2.90	$308.78	12.6%	10	Positive News
1.07%	NTRA Natera	$106.46 -1.9%	1 of 5 stars	3.00	$98.47	-7.5%	15	Analyst Upgrade Insider Selling
0.99%	MEDP Medpace	$393.30 +0.0%	5 of 5 stars	2.80	$443.00	12.6%	5
0.89%	RGEN Repligen	$171.94 +0.5%	4 of 5 stars	2.89	$197.75	15.0%	9	Positive News
0.73%	LEGN Legend Biotech	$45.16 -2.6%	3 of 5 stars	2.92	$82.74	83.2%	12	Earnings Report
0.70%	ASND Ascendis Pharma A/S	$121.12 -1.4%	1 of 5 stars	2.88	$176.88	46.0%	8
0.68%	PCVX Vaxcyte	$74.57 -1.2%	0 of 5 stars	3.00	$78.50	5.3%	4
0.68%	ITCI Intra-Cellular Therapies	$65.00 -2.3%	5 of 5 stars	2.90	$90.17	38.7%	10	Positive News
0.67%	EXEL Exelixis	$20.91 -1.5%	5 of 5 stars	2.59	$26.13	24.9%	17
0.66%	BPMC Blueprint Medicines	$104.96 -1.6%	1 of 5 stars	2.53	$102.65	-2.2%	17
0.66%	CYTK Cytokinetics	$59.53 -0.7%	4 of 5 stars	2.87	$81.60	37.1%	15
0.65%	BRKR Bruker	$75.07 -1.0%	5 of 5 stars	2.43	$84.86	13.0%	7	Dividend Announcement Analyst Revision High Trading Volume
0.59%	IONS Ionis Pharmaceuticals	$37.31 -0.8%	5 of 5 stars	2.71	$59.54	59.6%	14	Gap Down
0.56%	ROIV Roivant Sciences	$11.23 -1.6%	2 of 5 stars	2.90	$16.90	50.5%	10	Positive News
0.55%	RVMD Revolution Medicines	$39.41 +1.1%	3 of 5 stars	3.10	$43.20	9.6%	10
0.52%	HALO Halozyme Therapeutics	$44.71 -1.5%	5 of 5 stars	2.83	$53.14	18.9%	6	Positive News
0.48%	APLS Apellis Pharmaceuticals	$41.31 -1.6%	5 of 5 stars	2.87	$76.67	85.6%	15	Analyst Revision Positive News
0.45%	CRSP CRISPR Therapeutics	$56.22 +1.0%	3 of 5 stars	2.35	$73.93	31.5%	17	Gap Up
0.41%	ALKS Alkermes	$24.15 -1.3%	5 of 5 stars	2.50	$35.38	46.5%	10	Positive News
0.39%	KRYS Krystal Biotech	$164.10 +0.2%	5 of 5 stars	3.00	$171.00	4.2%	9	Short Interest ↑
0.38%	INSM Insmed	$24.77 -1.3%	5 of 5 stars	3.00	$44.71	80.5%	14
0.37%	BBIO BridgeBio Pharma	$30.09 -3.1%	5 of 5 stars	2.91	$48.00	59.5%	11	Gap Up
0.36%	MDGL Madrigal Pharmaceuticals	$220.06 +1.3%	4 of 5 stars	2.73	$345.09	56.8%	11	Gap Down
0.34%	CRNX Crinetics Pharmaceuticals	$51.40 -1.0%	4 of 5 stars	2.92	$58.42	13.7%	12	Gap Up
0.34%	FTRE Fortrea	$27.55 -0.9%	3 of 5 stars	2.67	$35.57	29.1%	9	Earnings Report
0.34%	RARE Ultragenyx Pharmaceutical	$41.87 -1.7%	4 of 5 stars	2.92	$87.85	109.8%	12	Positive News
0.32%	XENE Xenon Pharmaceuticals	$39.80 -1.3%	3 of 5 stars	3.00	$59.11	48.5%	9
0.31%	FOLD Amicus Therapeutics	$9.57 +0.7%	5 of 5 stars	2.86	$17.50	82.9%	7	Gap Up
0.30%	ALPN Alpine Immune Sciences	$64.97 +0.0%	2 of 5 stars	2.27	$52.33	-19.5%	11	Positive News High Trading Volume

This page (NASDAQ:IBB) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

iShares Biotechnology ETF Rating

iShares Biotechnology ETF Aggregate Rating and Price Target (2024)

IBB Aggregate Rating

IBB Aggregate Price Target

IBB Consensus Ratings of Holdings

Ratings for Stocks Held by iShares Biotechnology ETF

Ratings for the Top 50 IBB Holdings

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info